New Diagnostics and Emerging Biomarkers for Alzheimer's Disease

This webinar will review the current landscape of Alzheimer's disease biomarkers and diagnostics. The featured speakers will discuss blood-based biomarkers and also highlight emerging biomarkers, such as GFAP and YKL40 that may supplement the core ATN panel to further enhance the understanding of, and the ability to identify and differentiate neurodegenerative diseases.